TARDBP and amyotrophic lateral sclerosis: Based on these studies, inhibition of TDP‐43 phosphorylation by kinase inhibitors has been proposed as a potential therapeutic strategy for ALS (Liachko et al, 2013; Salado et al, 2014; Martinez‐Gonzalez et al, 2020).